April 12, 2022
1 min watch
Save
VIDEO: Advanced hidradenitis suppurativa management requires varied, creative strategies
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Christopher Sayed, MD, discusses “pearls” from the advanced management of hidradenitis suppurativa symposium at the American Academy of Dermatology Annual Meeting.
“We often have to approach HS with many different strategies,” Sayed, associate professor at University of North Carolina School of Dermatology and board member of the HS Foundation, said.
Reference:
- Micheletti R. F073 Symposium. Biologics and small molecules for HS. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Sayed reports serving as a speaker for AbbVie and Novartis; serving as a consultant for AbbVie, Aclaris, InflaRx, Novartis and UCB; serving as an investigator for AbbVie, Chemocentryx, Incyte, InflaRx, Novartis and UCB; and receiving a grant from AbbVie.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.